0000875320-24-000101.txt : 20240227 0000875320-24-000101.hdr.sgml : 20240227 20240227164407 ACCESSION NUMBER: 0000875320-24-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240223 FILED AS OF DATE: 20240227 DATE AS OF CHANGE: 20240227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atkinson Edward Morrow III CENTRAL INDEX KEY: 0001914164 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 24687735 MAIL ADDRESS: STREET 1: C/O 89BIO, INC. STREET 2: 142 SANSOME STREET, SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 wk-form4_1709070192.xml FORM 4 X0508 4 2024-02-23 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001914164 Atkinson Edward Morrow III C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Technical Ops. Off. 1 Common Stock 2024-02-23 4 F 0 1654 431.79 D 16855 D Common Stock 2024-02-26 4 S 0 883 425.70 D 15972 D Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 8/22/2023. /s/ Christiana Stevenson, Attorney-in-Fact 2024-02-27